Sign in

CIK 0002131524

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Braveheart Bio, Inc.

Sign in to watch
Ticker
BRVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
992981994
Phone
+1 415-707-6312
Business address
ONE LETTERMAN DR., BLDG. A, STE. A4-300, SAN FRANCISCO, CA, 94129
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-07 AH Bio Fund IV, L.P. 10% owner Conversion +9,132,420 9,132,420
2026-08-07 AH Bio Fund IV, L.P. 10% owner Purchase +1,100,000 $18.00 $19.8M 10,232,420
2026-08-07 AH Bio Fund IV, L.P. 10% owner Conversion · Series A Preferred Stock −40,000,000 0
2026-08-07 Chimovits Erez Director Conversion +9,132,420 10,235,159
2026-08-07 Chimovits Erez Director Purchase +1,666,667 $18.00 $30.0M 11,901,826
2026-08-07 Chimovits Erez Director Purchase +273,333 $18.00 $4.9M 273,333
2026-08-07 Chimovits Erez Director Conversion · Series A Preferred Stock −40,000,000 0
2026-08-07 ORBIMED ADVISORS LLC Director Conversion +9,132,420 10,235,159
2026-08-07 ORBIMED ADVISORS LLC Director Purchase +1,666,667 $18.00 $30.0M 11,901,826
2026-08-07 ORBIMED ADVISORS LLC Director Purchase +273,333 $18.00 $4.9M 273,333
2026-08-07 ORBIMED ADVISORS LLC Director Conversion · Series A Preferred Stock −40,000,000 0
2026-08-07 Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner Conversion +7,420,091 7,420,091
2026-08-07 Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner Conversion · Non-voting Series A preferred stock −32,500,000 0
2026-08-07 Rickey James Paul Chief Financial Officer Purchase +27,777 $18.00 $500K 520,927
2026-08-07 Viehbacher Christopher Director Purchase +83,333 $18.00 $1.5M 609,519
2026-08-07 Malek David I Director Purchase +4,166 $18.00 $75K 533,845
2026-08-07 Anderson Michele A. Chief Development Officer Purchase +1,111 $18.00 $20K 332,161
2026-08-07 Murdoch Travis CEO and President Purchase +83,333 $18.00 $1.5M 2,940,670
2026-08-07 Lubner David Charles Director Purchase +55,555 $18.00 $1000K 55,555
2026-08-07 Forbion Growth Opportunities Fund III Cooperatief U.A. 10% owner Conversion +9,132,420 9,720,546

Page 1 of 2 · 34 trades